Integrated DNA Technologies Acquires 1st BASE Oligonucleotide Business in Singapore
Integrated DNA Technologies (IDT) has acquired the oligonucleotide business of 1st BASE Pte. Ltd. IDT will now offer locally-manufactured oligos to researchers in Singapore and throughout the region from the company’s first synthesis facility in Asia.
Dr. Joseph Walder, IDT’s founder and Chief Executive Officer, stressed the commonalities that brought 1st BASE and IDT together. “We found natural partners in the people at 1st BASE, with whom we’ve been working for many years,” he noted. “Above all, IDT and 1st BASE shared a commitment both to consistently high-quality oligos and to personal service for customers, who we consider collaborators.” “As we thought about how to deliver the IDT advantage to scientists in Asia,” he added, “working with the 1st BASE team became the obvious choice.”
IDT has named its new company in Singapore 1st BASE Custom Oligos Pte. Ltd. (FBCO), and IDT will retain the “1st BASE” brand for the small scale DNA oligos that it synthesizes in Singapore.
Other news from the department business & finance
